BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8839857)

  • 1. Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R.
    Iversen PO; Rodwell RL; Pitcher L; Taylor KM; Lopez AF
    Blood; 1996 Oct; 88(7):2634-9. PubMed ID: 8839857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice.
    Iversen PO; Lewis ID; Turczynowicz S; Hasle H; Niemeyer C; Schmiegelow K; Bastiras S; Biondi A; Hughes TP; Lopez AF
    Blood; 1997 Dec; 90(12):4910-7. PubMed ID: 9389708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
    Frankel AE; Lilly M; Kreitman R; Hogge D; Beran M; Freedman MH; Emanuel PD; McLain C; Hall P; Tagge E; Berger M; Eaves C
    Blood; 1998 Dec; 92(11):4279-86. PubMed ID: 9834234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis of hemopoietic cells by the human granulocyte-macrophage colony-stimulating factor mutant E21R.
    Iversen PO; To LB; Lopez AF
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2785-9. PubMed ID: 8610118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apoptosis-inducing granulocyte-macrophage colony-stimulating factor (GM-CSF) analog E21R functions through specific regions of the heterodimeric GM-CSF receptor and requires interleukin-1beta-converting enzyme-like proteases.
    Iversen PO; Hercus TR; Zacharakis B; Woodcock JM; Stomski FC; Kumar S; Nelson BH; Miyajima A; Lopez AF
    J Biol Chem; 1997 Apr; 272(15):9877-83. PubMed ID: 9092524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors.
    Emanuel PD; Snyder RC; Wiley T; Gopurala B; Castleberry RP
    Blood; 2000 Jan; 95(2):639-45. PubMed ID: 10627474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.
    Kochetkova M; Iversen PO; Lopez AF; Shannon MF
    J Clin Invest; 1997 Jun; 99(12):3000-8. PubMed ID: 9185524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of granulocyte-macrophage colony-stimulating factor gene expression by a tumor necrosis factor specific ribozyme in juvenile myelomonocytic leukemic cells.
    Iversen PO; Sioud M
    Blood; 1998 Dec; 92(11):4263-8. PubMed ID: 9834232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulating factor for growth in vitro and in vivo.
    Ramshaw HS; Bardy PG; Lee MA; Lopez AF
    Exp Hematol; 2002 Oct; 30(10):1124-31. PubMed ID: 12384142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells.
    Jakupovic I; Grandage VL; Linch DC; Khwaja A
    Blood; 2004 Apr; 103(8):3230-2. PubMed ID: 15070708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells.
    Geissler K; Ohler L; Födinger M; Virgolini I; Leimer M; Kabrna E; Kollars M; Skoupy S; Bohle B; Rogy M; Lechner K
    J Exp Med; 1996 Oct; 184(4):1377-84. PubMed ID: 8879210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific human granulocyte-macrophage colony-stimulating factor antagonists.
    Hercus TR; Bagley CJ; Cambareri B; Dottore M; Woodcock JM; Vadas MA; Shannon MF; Lopez AF
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5838-42. PubMed ID: 8016076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth.
    Iversen PO; Emanuel PD; Sioud M
    Blood; 2002 Jun; 99(11):4147-53. PubMed ID: 12010819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.
    Ohtsuka Y; Manabe A; Kawasaki H; Hasegawa D; Zaike Y; Watanabe S; Tanizawa T; Nakahata T; Tsuji K
    Blood; 2005 Nov; 106(9):3134-41. PubMed ID: 16046524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia.
    Bernard F; Thomas C; Emile JF; Hercus T; Cassinat B; Chomienne C; Donadieu J
    Blood; 2002 Apr; 99(7):2615-6. PubMed ID: 11895804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6.
    Li Y; Valeriote F; Chen B
    Exp Hematol; 1996 Feb; 24(2):94-100. PubMed ID: 8641372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor (GM-CSF) acts independently of the beta common subunit of the GM-CSF receptor to prevent inner cell mass apoptosis in human embryos.
    Sjöblom C; Wikland M; Robertson SA
    Biol Reprod; 2002 Dec; 67(6):1817-23. PubMed ID: 12444058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia.
    Nakazawa Y; Matsuda K; Kurata T; Sueki A; Tanaka M; Sakashita K; Imai C; Wilson MH; Koike K
    J Hematol Oncol; 2016 Mar; 9():27. PubMed ID: 26983639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex.
    McClure BJ; Hercus TR; Cambareri BA; Woodcock JM; Bagley CJ; Howlett GJ; Lopez AF
    Blood; 2003 Feb; 101(4):1308-15. PubMed ID: 12393492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.